Marques Carine Santana Ferreira, Machado Júnior Jorge Barreto, Andrade Lucas Rannier de Melo, Andrade Luciana Nalone, Santos André Luis Souza Dos, Cruz Maria do Socorro Pires E, Chaud Marco, Fricks Alini Tinoco, Severino Patrícia
Programa de Pós-Graduação em Biotecnologia Industrial, Universidade Tiradentes, Aracaju, SE, Brasil.
Laboratório de Nanotecnologia e Nanomedicina, Instituto de Tecnologia e Pesquisa, Aracaju, SE, Brasil.
Rev Soc Bras Med Trop. 2019 Apr 11;52:e20180246. doi: 10.1590/0037-8682-0246-2018.
Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects.
This study investigated available literature, including patents and scientific articles, to identify advances in the use of nanotechnology for the treatment of leishmaniasis.
Our findings revealed a stable number of patents and scientific articles published over the past five years.
There is a need to intensify research on the use of nanotechnology for the treatment of leishmaniasis.